Copyright
©2011 Baishideng Publishing Group Co.
World J Cardiol. Nov 26, 2011; 3(11): 351-358
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.351
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.351
Ref. | Clinical setting | Definition |
Landefeld et al[53] | Various | Fatal, life-threatening, potentially life-threatening, causing severe blood loss, leading to surgical treatment or moderate acute/subacute blood loss not explained by surgery/trauma |
Palareti et al[32] | Various | Fatal intracranial (documented by imaging); ocular (with blindness); articular; retroperitoneal; requiring surgery/angiographic intervention; associated to Hb decrease ≥ 2 g/dL or need for ≥ 2 blood units transfusion |
Beyth et al[54] | Various | Overt bleeding leading to ≥ 2 blood units loss in ≤ 7 d, or life-threatening |
Gage et al[55] | AF | ICD-9CM codes for bleed in any location |
Shireman et al[56] | AF | Hospitalization for “major acute bleeding” (including gastrointestinal or intracranial hemorrhage) |
- Citation: Rubboli A, Becattini C, Verheugt FW. Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol 2011; 3(11): 351-358
- URL: https://www.wjgnet.com/1949-8462/full/v3/i11/351.htm
- DOI: https://dx.doi.org/10.4330/wjc.v3.i11.351